Clinical Trial Details

Trial ID: L0878
Source ID: IRCT2015030721358N1
Associated Drug: Omega-3 Fatty Acids
Title: Investigation of mechanism of supplementation effect with omega-3 on lipid profile and peroxidation , inflammatory markers, insulin resistance and liver function in patients with non-alcoholic fatty liver (NAFL) compared with control group.
Acronym: --
Status: Not Recruiting
Study Results: No Results Available
Results: --
Conditions: (Nonalcoholic fatty liver disease (NAFLD. <br>(Nonalcoholic fatty liver disease (NAFLD;(Nonalcoholic fatty liver disease (NAFLD
Interventions: Intervention 1: intervention group: Omega-3 supplement with effective dosage of 900 mg/day, 3*300 mg capsules per day for 2 month. Intervention 2: control group: 3 capsules of placebo per day for 2 month.;Treatment - Drugs;Placebo;intervention group: Omeg
Outcome Measures: Lipid profile. Timepoint: before intervention and 2 months after intervention. Method of measurement: mg/dl with autoanalyzer.;Inflammatory markers. Timepoint: before intervention and 2 months after intervention. Method of measurement: ELISA.;Sugar profile. Timepoint: before intervention and 2 months after intervention. Method of measurement: mg/dl with autoanalyzer.;Insulin Resistance. Timepoint: before intervention and 2 months after intervention. Method of measurement: HOMA-IR.Liver enzymes. Timepoint: before intervention and 2 months after intervention. Method of measurement: Autoanalyzer.
Sponsor/Collaborators: Ahvaz Jundishapur University of Medical Sciences
Gender: All
Age: 18 yearsno limit
Phases: Not applicable
Enrollment: 40
Study Type: interventional
Study Designs: Randomization: Randomized, Blinding: Double blinded, Placebo: Used, Assignment: Parallel, Purpose: Treatment.
Start Date: 11/04/2015
Completion Date: --
Results First Posted: --
Last Update Posted: 22 February 2018
Locations: Iran (Islamic Republic of)
URL: http://en.irct.ir/trial/18740